Ritter Daniher Financial Advisory’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.1K Sell
1,644
-2,682
-62% -$120K 0.01% 247
2026
Q1
$208K Sell
4,326
-94
-2% -$4.38K 0.04% 154
2025
Q4
$214K Buy
+4,420
New +$219K 0.04% 158
2022
Q2
Sell
-68
Closed -$3K 264
2022
Q1
$3K Hold
68
﹤0.01% 217
2021
Q4
$3K Hold
68
﹤0.01% 211
2021
Q3
$3K Hold
68
﹤0.01% 197
2021
Q2
$4K Hold
68
﹤0.01% 181
2021
Q1
$3K Hold
68
﹤0.01% 177
2020
Q4
$3K Buy
+68
New +$3.35K ﹤0.01% 171

Other funds holding SNY

Ritter Daniher Financial Advisory's SNY Position: Q2 2026 in Review

Ritter Daniher Financial Advisory reduced its Sanofi (SNY) stake by 62% in Q2 2026, selling an estimated $120K and leaving 1,644 shares worth $70.1K. The position accounts for 0.01% of the portfolio, ranked #247.

Ritter Daniher Financial Advisory first reported a position in SNY in Q4 2020 and has held it in 9 quarters since. The position peaked at $214K in Q4 2025. 94 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Ritter Daniher Financial Advisory held 1,644 shares of Sanofi worth $70.1K as of Q2 2026.
  • Ritter Daniher Financial Advisory sold 2,682 Sanofi shares in Q2 2026, an estimated $120K.
  • Sanofi made up 0.01% of Ritter Daniher Financial Advisory's portfolio in Q2 2026, its #247 holding.
  • Ritter Daniher Financial Advisory first reported a position in Sanofi in Q4 2020 and has held it in 9 quarters since.
  • Ritter Daniher Financial Advisory's Sanofi position peaked at $214K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Ritter Daniher Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.